Publications by authors named "Beverly Langford-Wiley"
Lancet Respir Med
January 2024
Article Synopsis
- The study investigates the use of eosinophil biomarker-directed treatment with oral prednisolone during COPD exacerbations, aiming to reduce prednisolone usage while minimizing adverse effects.*
-
- Conducted across 14 UK primary care practices, the STARR2 trial randomly assigned participants to either eosinophil-directed treatment or standard care, masking both staff and participants to treatment allocations.*
-
- The primary outcome measured was treatment failure at 30 days, which included the need for additional antibiotics or steroids, hospitalizations, or death, with safety analyses conducted for all participants.*
